萨吉梅生物科学 SGMT
$9.85 +$0.73 (+8.00%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $9.85 0.00%
开盘$9.25
昨收$9.12
当日区间$9.02 – $9.87
成交量857.9K
市值$698.45M
市盈率（TTM）–
股息率–
SGMT 相关新闻
匹配 Sagimet Biosciences 或代码 SGMT 的头条新闻，按最新排序。
- Barclays Upgrades Sagimet Biosciences(SGMT.US) to Buy Rating, Raises Target Price to $18 正面
- Cantor Fitzgerald Initiates Sagimet Biosciences(SGMT.US) With Buy Rating, Announces Target Price $26
- JonesTrading Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $31
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)
- Goldman Sachs Initiates Sagimet Biosciences(SGMT.US) With Sell Rating, Announces Target Price $7
- Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Sagimet Biosciences, Inc. Class A (SGMT)
- A Quick Look at Today's Ratings for Sagimet Biosciences(SGMT.US), With a Forecast Between $25 to $49
- Oppenheimer Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $33
- H.C. Wainwright Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $29
- Analysts Are Bullish on Top Healthcare Stocks: Monte Rosa Therapeutics (GLUE), Sagimet Biosciences, Inc. Class A (SGMT) 正面
- Wedbush Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $28
- Analysts Offer Insights on Healthcare Companies: Sagimet Biosciences, Inc. Class A (SGMT) and Revolution Medicines (RVMD)
- JonesTrading Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $31
- H.C. Wainwright Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $29
- Leerink Partners Maintains Sagimet Biosciences(SGMT.US) With Buy Rating
暂无评论——快来第一个聊聊 SGMT。
登录后参与讨论。